United States · FDA National Drug Code directory
CELECOXIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75834-239_482c41c4-9795-076e-e063-6394a90a3a85
- Product NDC
- 75834-239
- Form
- CAPSULE
- Composition / generic term
- CELECOXIB
- Labeler
- NIVAGEN PHARMACEUTICALS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200903
- Source listing expiry
- 20271231
Source-listed ingredients
- CELECOXIB — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (75834-239-05) · 75834-239-05
- 100 CAPSULE in 1 BLISTER PACK (75834-239-11) · 75834-239-11
- 60 CAPSULE in 1 BOTTLE (75834-239-60) · 75834-239-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →